Placeholder Banner

BIO Comments to FDA on Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products

August 3, 2023

In response to the agency's request for information (Docket No. FDA-2023-N-0743-0002), BIO provides detailed comments.

Download Full Comments Below
BIO Comment Letter - FDA-2023-N-0743
Discover More
In response to the request for information and comments, BIO submitted general comments and recommended edits (FDA-2017-D-6530)
In response to the request for information and comments, BIO submitted general comments and recommended edits (FDA-2023-D-2318)
BIO provided general comments and recommended edits Re: FDA-2023-D-3031